Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Alexion Pharmaceuticals Inc. (ALXN), Cheshire, Conn. Procter & Gamble Co. (PG), Cincinnati, Ohio Product: Pexelizumab (5G1.1-SC) Business: Cardiovascular Molecular target:
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury